REFRACTORY LYMPHOBLASTIC LYMPHOMA
Clinical trials for REFRACTORY LYMPHOBLASTIC LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY LYMPHOBLASTIC LYMPHOMA trials appear
Sign up with your email to follow new studies for REFRACTORY LYMPHOBLASTIC LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New 'Triple-Target' immune therapy enters human testing for tough blood cancers
Disease control Recruiting nowThis early-stage trial is testing the safety and best dose of a new type of CAR-T cell therapy. The therapy uses a patient's own immune cells, modified to attack three different markers (CD19, CD20, CD22) found on cancer cells. It is for adults with certain advanced blood cancers…
Matched conditions: REFRACTORY LYMPHOBLASTIC LYMPHOMA
Phase: PHASE1 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated Apr 04, 2026 01:51 UTC
-
Six-Drug attack on tough blood cancers shows promise
Disease control Recruiting nowThis study is testing a combination of six chemotherapy drugs for people whose acute lymphoblastic leukemia (ALL) or lymphoblastic lymphoma has come back or hasn't responded to previous treatments. The goal is to see if this intensive combination is safe and can effectively contr…
Matched conditions: REFRACTORY LYMPHOBLASTIC LYMPHOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC